Correlation Between Enliven Therapeutics and ANI Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and ANI Pharmaceuticals, you can compare the effects of market volatilities on Enliven Therapeutics and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and ANI Pharmaceuticals.

Diversification Opportunities for Enliven Therapeutics and ANI Pharmaceuticals

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Enliven and ANI is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and ANI Pharmaceuticals go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and ANI Pharmaceuticals

Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 1.34 times more return on investment than ANI Pharmaceuticals. However, Enliven Therapeutics is 1.34 times more volatile than ANI Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest  2,322  in Enliven Therapeutics on August 24, 2024 and sell it today you would earn a total of  219.00  from holding Enliven Therapeutics or generate 9.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Enliven Therapeutics  vs.  ANI Pharmaceuticals

 Performance 
       Timeline  
Enliven Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
ANI Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Enliven Therapeutics and ANI Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enliven Therapeutics and ANI Pharmaceuticals

The main advantage of trading using opposite Enliven Therapeutics and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.
The idea behind Enliven Therapeutics and ANI Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios